Month: April 2013

Memory loss, dementia, and cardiovascular disease prevention are the main reasons many of you wonder if you should be taking gingko (Gingko biloba). There was hope for years in gingko. It works to improve blood flow through increased release of nitric oxide, and it works as an anti-inflammatory so it was believed to be neuroprotective…. Read More

Recent product recalls from compounding pharmacies have been getting a lot of attention. Here are five things you need to know about compounding and why the recalls have been happening: 1. Compounding pharmacies are pharmacies that are able to make specific drugs for patients. This includes compounding of discontinued or unavailable medications, special formulations (suppositories,… Read More

APP Pharmaceuticals has announced a shortage of both forms of their fluphenazine injection, used for the long-term management of conditions such as schizophrenia. The fluphenazine decanoate 25mg/ml 5 ml vial is currently backordered, with an estimated rerelease in the third quarter of 2013. The fluphenazine hydrochloride 2.5mg/ml 20 ml vial is also backordered, with a new shipment… Read More

Recently Pfizer, the manufacturer of Levoxyl, has issued a national recall of all Levoxyl products from retail pharmacies. As of April 2013, pharmacies will no longer have any strengths of Levoxyl available. Here’s what you need to know: What is Levoxyl?  Levoxyl (levothyroxine) is used to treat low thyroid levels and to prevent certain types… Read More

Lifelong treatment with a medication is a tall order for some people—so it isn’t all that surprising that discontinuation rates are high for some of the most popular cholesterol medications, the statin drugs. Why is this a problem? If you’re on a drug to lower your cholesterol, you will need to keep taking your prescription or your… Read More

Sandoz, the manufacturer of generic reserpine has announced an update to the current backorder situation. The 0.25 mg and 0.1 mg tablets were originally supposed to be available again at the end of April 2013 and beginning of May 2013. Now, the predicted next available supply for both strengths has been pushed back to August… Read More

The manufacturers of restless leg syndrome and postherpetic neuralgia treatment Horizant (extended-release gabapentin) have made an announcement that the 600 mg tablet is temporarily backordered. XenoPort, a biopharmaceutical company, originally developed the drug, and GlaxoSmithKline has been responsible for manufacturing and commercialization (advertising and distributing) of Horizant until April 30, 2013. There’s a manufacturing delay surrounding the… Read More

four types of medication routes - pad, cream, injection and bottle

You are all stopped up and can’t find an obvious reason. Look over your medication list and you may find the source. Constipation has many causes but medications are among the most common. First, if your stools are too hard or too small or pooping is too difficult or infrequent you are constipated. Officially, constipation… Read More

Big news this week when the FDA announced approval of Diclegis for morning sickness. What is it? Diclegis is a delayed release tablet that is a mixture of doxylamine succinate and vitamin B6 (pyridoxine HCl). Diclegis is a mixture of an antihistamine and vitamin B6. Who will use it? The FDA has approved the use… Read More

Can’t remember the name of a prescription, or having trouble telling which pill is which? Try the new GoodRx Pill Identifier! Search by imprint (the text and markings on the pill), shape, and color to find the name and strength of your prescription, or browse using our list of popular imprints. If you have your… Read More